Pharmacogenetics is a groundbreaking field that aims to personalize drug treatment based on an individual's genetic profile. By understanding the associations between genetic variants and treatment outcomes in schizophrenia spectrum disorders (SSD), clinicians can optimize therapeutic efficacy and improve patient outcomes. This in-depth review delves into the current state of pharmacogenetics in SSD (Pharmacogenetics and Proteins) and its potential for personalized treatment.
Key Takeaways:
Pharmacogenetics aims to personalize drug treatment based on an individual's genetic profile.
The field shows promise in improving treatment efficacy and outcomes in schizophrenia spectrum disorders.
Understanding genetic variants can guide clinicians in selecting the most appropriate dose and medication for patients.
Challenges such as reproducibility and standardization exist, but ongoing research seeks to overcome them.
Implementing pharmacogene...
_____
If you are a member of our Association, please log in below to continue reading our exclusive content.
Not a member yet? Discover the benefits of joining our network and gain access to exclusive content like this for only $29.95 per month. Learn More and Sign Up
